89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 71 filers reported holding 89BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,881,039 | -18.7% | 2,129,601 | -0.2% | 0.09% | -12.0% |
| Q2 2023 | $40,437,500 | +12.8% | 2,133,905 | -9.3% | 0.10% | +11.1% |
| Q1 2023 | $35,837,941 | +1194498.0% | 2,353,115 | +239769.0% | 0.09% | – |
| Q2 2022 | $3,000 | -40.0% | 981 | -26.0% | 0.00% | – |
| Q1 2022 | $5,000 | +400.0% | 1,326 | +10950.0% | 0.00% | – |
| Q4 2021 | $1,000 | -94.4% | 12 | -98.3% | 0.00% | – |
| Q4 2020 | $18,000 | – | 721 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |